NFKB1 and endothelial dysfunction: Our previous studies also showed that an anti-HMGB1 antibody attenuated RAGE expression and its downstream effector NF-κB activation in Ang II-induced endothelial dysfunction and cardiomyocyte hypertrophy [11,34].